Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-03-10
1990-03-27
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
549305, 558 33, 560119, 562501, 568303, 568348, A61K 31215, C07C 6974
Patent
active
049121340
ABSTRACT:
Azulene derivatives of the following formula ##STR1## wherein R.sup.1 stands for an alkyl group of 1 to 3 carbon atoms, R.sup.2 stands for an alkyl group of 1 to 3 carbon atoms, and R.sup.3 is at the 5- or 6-position and stands for an alkyl group of 1 to 6 carbon atoms, an aryl group of 6 to 9 carbon atoms or an aralkyl group of 7 to 10 carbon atoms; have antihyperlipidemic activity. Many of the compounds are also novel per se.
REFERENCES:
43rd Annual Meeting of the Chemical Society of Japan, Mar. 1981, in Tokyo, Japan, Abstract II P889 with English translation.
The Tohoku Local Meeting of the Chemical Society of Japan in Fukushima, Japan, Oct. 2, 3, 1981, with English translation.
Hiwatashi Osamu
Kato Nobuo
Meguro Takashi
Nakamura Toru
Okutsu Masaru
Ajinomoto Company, Inc.
Shippen Michael L.
LandOfFree
Azulene derivatives and pharmaceutical compositions containing t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azulene derivatives and pharmaceutical compositions containing t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azulene derivatives and pharmaceutical compositions containing t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1651463